Patents Assigned to Potenza Therapeutics, Inc.
  • Anti-TIGIT antigen-binding proteins and methods of uses thereof
    Patent number: 11590224
    Abstract: Provided herein are antigen-binding proteins (ABPs) that selectively bind to TIGIT and its isoforms and homologs, and compositions comprising the ABPs. Also provided are methods of using the ABPs, such as therapeutic and diagnostic methods.
    Type: Grant
    Filed: October 22, 2019
    Date of Patent: February 28, 2023
    Assignee: Potenza Therapeutics, Inc.
    Inventors: Daniel Hicklin, William Winston, Cynthia S. Dugan, Nels P. Nielson
  • Anti-TIGIT antigen-binding proteins and methods of use thereof
    Patent number: 11453720
    Abstract: Provided herein are antigen-binding proteins (ABPs) that selectively bind to TIGIT and its isoforms and homologs, and compositions comprising the ABPs. Also provided are methods of using the ABPs, such as therapeutic and diagnostic methods.
    Type: Grant
    Filed: March 30, 2018
    Date of Patent: September 27, 2022
    Assignee: Potenza Therapeutics, Inc.
    Inventors: Nels P. Nielson, Daniel Hicklin, Cynthia Seidel-Dugan, William Winston, Heather Brodkin, Jose-Andres Salmeron-Garcia, Christopher James Nirschl, Philipp Steiner
  • Anti-neuropilin antigen-binding proteins and methods of use thereof
    Patent number: 11186644
    Abstract: Provided herein are antibodies, or antigen binding fragments thereof, that selectively bind to NRP-1 and its isoforms and homologs, and compositions comprising the antibodies, or antigen binding fragments thereof. Also provided are methods of using the antibodies, or antigen binding fragments thereof, such as therapeutic and diagnostic methods.
    Type: Grant
    Filed: January 3, 2019
    Date of Patent: November 30, 2021
    Assignee: Potenza Therapeutics, Inc.
    Inventors: Daniel Hicklin, Cynthia Seidel-Dugan, William Winston, Jose-Andres Salmeron-Garcia, Nels P. Nielson, Heather Brodkin
  • Anti-GITR antigen-binding proteins and methods of use thereof
    Patent number: 10988545
    Abstract: Provided herein are antigen-binding proteins (ABPs) that selectively bind to GITR and its isoforms and homologs, and compositions comprising the ABPs. Also provided are methods of using the ABPs, such as therapeutic and diagnostic methods.
    Type: Grant
    Filed: February 20, 2018
    Date of Patent: April 27, 2021
    Assignee: Potenza Therapeutics, Inc.
    Inventors: Daniel Hicklin, Cynthia Seidel-Dugan, William Winston, Jose-Andres Salmeron-Garcia, Heather Brodkin, Sonja Kleffel, Nels P. Nielson
  • Anti-TIGIT antigen-binding proteins and methods of use thereof
    Patent number: 10507244
    Abstract: Provided herein are antigen-binding proteins (ABPs) that selectively bind to TIGIT and its isoforms and homologs, and compositions comprising the ABPs. Also provided are methods of using the ABPs, such as therapeutic and diagnostic methods.
    Type: Grant
    Filed: June 19, 2017
    Date of Patent: December 17, 2019
    Assignee: Potenza Therapeutics, Inc.
    Inventors: Daniel Hicklin, William Winston, Cynthia Seidel-Dugan, Nels P. Nielson
  • Anti-neuropilin antigen-binding proteins and methods of use thereof
    Patent number: 10227413
    Abstract: Provided herein are antigen-binding proteins (ABPs) that selectively bind to NRP-1 and its isoforms and homologs, and compositions comprising the ABPs. Also provided are methods of using the ABPs, such as therapeutic and diagnostic methods.
    Type: Grant
    Filed: February 20, 2018
    Date of Patent: March 12, 2019
    Assignee: Potenza Therapeutics, Inc.
    Inventors: Daniel Hicklin, Cynthia Seidel-Dugan, William Winston, Jose-Andres Salmeron-Garcia, Nels P. Nielson, Heather Brodkin
  • Anti-TIGIT antigen-binding proteins and methods of use thereof
    Patent number: 9713641
    Abstract: Provided herein are antigen-binding proteins (ABPs) that selectively bind to TIGIT and its isoforms and homologs, and compositions comprising the ABPs. Also provided are methods of using the ABPs, such as therapeutic and diagnostic methods.
    Type: Grant
    Filed: February 13, 2017
    Date of Patent: July 25, 2017
    Assignee: Potenza Therapeutics, Inc.
    Inventors: Daniel Hicklin, William Winston, Cynthia S. Dugan, Nels P. Nielson